Home/Filings/4/0000899243-21-045363
4//SEC Filing

Civik Thomas 4

Accession 0000899243-21-045363

CIK 0001782223other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 1:21 PM ET

Size

5.3 KB

Accession

0000899243-21-045363

Insider Transaction Report

Form 4
Period: 2021-11-18
Civik Thomas
Director
Transactions
  • Purchase

    Common Stock

    2021-11-18$12.74/sh+15,700$200,01815,700 total(indirect: By Trust)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.47 to $13.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  • [F2]These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001723092

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 1:21 PM ET
Size
5.3 KB